A detailed history of Huntington National Bank transactions in Codexis, Inc. stock. As of the latest transaction made, Huntington National Bank holds 2 shares of CDXS stock, worth $7. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2
Previous 2 -0.0%
Holding current value
$7
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

SELL
$1.5 - $3.75 $2,596 - $6,491
-1,731 Reduced 99.88%
2 $0
Q2 2023

Aug 11, 2023

BUY
$2.21 - $4.43 $3,825 - $7,668
1,731 Added 86550.0%
1,733 $4,000
Q2 2022

Aug 09, 2022

SELL
$8.35 - $21.89 $2,538 - $6,654
-304 Reduced 99.35%
2 $0
Q1 2022

May 10, 2022

SELL
$16.97 - $31.93 $169 - $319
-10 Reduced 3.16%
306 $6,000
Q4 2021

Jan 21, 2022

SELL
$25.61 - $41.78 $3,047 - $4,971
-119 Reduced 27.36%
316 $10,000
Q3 2021

Oct 28, 2021

BUY
$19.65 - $27.99 $8,547 - $12,175
435 New
435 $10,000

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $257M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Huntington National Bank Portfolio

Follow Huntington National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.